← The Wire
KNSANasdaq
Kiniksa Pharmaceuticals International, plc
Pharmaceutical Preparations · CIK 1730430
Developing and commercializing novel therapies for diseases with unmet need, focusing on cardiovascular indications
red 8-K · 90d
$3.99B
Market cap
$62.41
Last close
+5.4%
1D
+9.2%
5D
1.5M
Volume
Price · last 39 sessions+8.3%
May 4L $46.92 · H $62.41Jun 29
163
Total filings
May 29, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 29, 20268-KMaterial AgreementMay 26, 20268-KExecutive ChangeMay 1, 20268-KResults of OperationsApr 28, 20268-KResults of OperationsFeb 24, 20268-KExecutive ChangeJan 14, 20268-KResults of OperationsJan 12, 20268-KResults of OperationsOct 28, 20258-KReg FD DisclosureSep 3, 20258-KResults of OperationsJul 29, 20258-KReg FD DisclosureJun 5, 20258-KShareholder VoteJun 3, 20258-KResults of OperationsApr 29, 20258-KExecutive ChangeApr 23, 20258-KAgreement Terminated · Results of OperationsFeb 25, 20258-KResults of OperationsJan 13, 20258-KResults of OperationsOct 29, 20248-KExecutive ChangeOct 7, 20248-KResults of OperationsJul 23, 20248-KMaterial AgreementJun 25, 20248-KCompany UpdateJun 14, 20248-KShareholder VoteJun 5, 20248-KResults of OperationsApr 23, 20248-KReg FD DisclosureApr 2, 20248-KCompany UpdateMar 29, 20248-KResults of OperationsFeb 28, 20248-KResults of Operations · Reg FD DisclosureJan 4, 20248-KResults of OperationsOct 31, 20238-KResults of OperationsJul 25, 20238-KShareholder VoteJun 7, 20238-KResults of OperationsMay 2, 20238-KReg FD DisclosureMar 13, 20238-KResults of OperationsFeb 28, 20238-KResults of OperationsJan 9, 20238-KResults of OperationsNov 1, 20228-KMaterial Agreement · Results of OperationsAug 3, 20228-KShareholder VoteJun 30, 20228-KResults of OperationsMay 3, 20228-KMaterial Agreement · Results of OperationsFeb 22, 20228-KResults of OperationsJan 10, 20228-KExecutive ChangeJan 3, 20228-KResults of OperationsNov 1, 20218-KResults of OperationsAug 3, 20218-KShareholder VoteJul 6, 20218-KExecutive ChangeMay 12, 20218-KResults of OperationsMay 4, 20218-KExecutive ChangeApr 28, 20218-KMaterial AgreementMar 3, 20218-KResults of OperationsFeb 23, 20218-KResults of OperationsJan 11, 20218-KExecutive ChangeDec 22, 20208-KMaterial AgreementNov 10, 20208-KResults of OperationsNov 5, 20208-KReg FD DisclosureOct 26, 20208-KResults of OperationsJul 30, 20208-KExecutive ChangeJul 28, 20208-KMaterial Agreement · Results of OperationsJul 24, 20208-KMaterial AgreementJul 15, 20208-KShareholder VoteJul 7, 20208-KReg FD DisclosureJun 29, 20208-KMaterial Agreement · Equity IssuanceMay 18, 20208-KResults of OperationsApr 28, 20208-KReg FD DisclosureApr 22, 20208-KResults of OperationsFeb 26, 20208-KExecutive ChangeFeb 5, 20208-KResults of Operations · Reg FD DisclosureJan 13, 20208-KExecutive ChangeDec 16, 20198-KExecutive ChangeNov 14, 20198-KResults of OperationsOct 28, 20198-KResults of Operations · Reg FD DisclosureAug 12, 20198-KShareholder VoteJun 4, 20198-KResults of OperationsMay 2, 20198-KExecutive Change · Results of OperationsMar 7, 20198-KEquity IssuanceFeb 1, 20198-KReg FD DisclosureJan 28, 20198-KMaterial AgreementNov 13, 20188-KResults of OperationsNov 1, 20188-KReg FD DisclosureSep 17, 20188-KReg FD DisclosureSep 13, 20188-KResults of OperationsAug 6, 2018
Insider Activity
In the 90 days to Mar 9, 2026: 4 sold $6.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 18,741 | $46.24 | $867K |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 17,981 | $45.58 | $820K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 22,223 | $44.88 | $997K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 12,063 | $44.20 | $533K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 5,714 | $45.92 | $262K |
| Feb 12, 2026 | Quart Barry DDirector | Sell | 2,690 | $45.00 | $121K |
| Feb 10, 2026 | Quart Barry DDirector | Sell | 110 | $45.00 | $5K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 9,114 | $42.85 | $391K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 8,731 | $43.72 | $382K |
| Feb 4, 2026 | Quart Barry DDirector | Sell | 2,602 | $45.02 | $117K |
| Feb 3, 2026 | Quart Barry DDirector | Sell | 12,528 | $45.27 | $567K |
| Feb 2, 2026 | Quart Barry DDirector | Sell | 830 | $45.00 | $37K |
| Jan 8, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 12,000 | $41.89 | $503K |
| Dec 15, 2025 | Quart Barry DDirector | Sell | 20,129 | $41.51 | $836K |
| Dec 15, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $501K |
| Dec 8, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.8M |
| Nov 26, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $9K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 11,825 | $41.30 | $488K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 645 | $40.08 | $26K |
| Nov 12, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $815K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance